期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
醛糖还原酶抑制剂CT-112治疗糖尿病患者角膜上皮病变:随机化安慰剂对照临床试验 被引量:1
1
作者 Nakahara M. Miyata K. +2 位作者 Otani s. s. amano 邢咏新 《世界核心医学期刊文摘(眼科学分册)》 2005年第8期37-38,共2页
Aim: To evaluate the efficacy of topical aldose reductase inhibitor CT-112 (5 -[3-ethoxy-4-pentyloxyphenyl]2,4-thiazolidinedione) on corneal epitheli al barrier function in diabetic patients. Methods: This was a prosp... Aim: To evaluate the efficacy of topical aldose reductase inhibitor CT-112 (5 -[3-ethoxy-4-pentyloxyphenyl]2,4-thiazolidinedione) on corneal epitheli al barrier function in diabetic patients. Methods: This was a prospective, randomi sed, double masked placebo controlled study. 34 eyes of 34 diabetic patients wer e randomly assigned treatment with 0.25%eye drops of CT-112 (n=22) or a placeb o (n=12) four times a day for 8 weeks. Corneal fluorescein staining and corneal sensation were examined before treatment as well as 4 and 8 weeks after administ ration. Corneal epithelial permeability to fluorescence was measured with an ant erior fluorophotometer. Results: Average scores of superficial punctate keratopa thy and corneal sensitivity did not differ significantly between the two groups at any time. Whereas average fluorescein concentrations did not differ significa ntly for the CT-112 and placebo groups before treatment, they did differ signif icantly 4 and 8 weeks after treatment (4 weeks, p=0.0327; 8 weeks, p=0.0143). Co nclusion: The topical aldose reductase inhibitor, CT-112 improves the corneal e pithelial barrier function in diabetic patients. 展开更多
关键词 CT-112 随机化 角膜上皮 通透性 角膜荧光素染色 安慰剂对照 屏障功能 荧光素 荧光光度计 平均分值
下载PDF
皮肤Fibulin-5沉积量随年龄及紫外线B暴露增加而减少,在日光性弹力组织变性中增加
2
作者 Kadoya K. sasaki T. +2 位作者 Kostka G. s. amano 王琼 《世界核心医学期刊文摘(皮肤病学分册)》 2005年第12期49-50,共2页
Background: Fibulin- 5 was recently found as a secreted extracellular matrix protein that functions as a scaffold for elastic fibres. However, the distribution of fibulin- 5 in human skin and its changes during the ag... Background: Fibulin- 5 was recently found as a secreted extracellular matrix protein that functions as a scaffold for elastic fibres. However, the distribution of fibulin- 5 in human skin and its changes during the ageing process are not known. Objectives: To explore the involvement of fibulin- 5 in skin ageing, the age- dependent changes in fibulin- 5 localization in human skin were examined compared with those of other elastic fibre components including elastin, fibrillin- 1 and fibulin- 2. Methods: The distribution of elastin, fibrillin- 1, fibrillin- 2, fibulin- 2 and fibulin- 5 was investigated by means of immunohistochemistry using their specific antibodies. Skin samples were recovered from 12 healthy subjects undergoing plastic surgery. Ultraviolet (UV) B- irradiated or control nonirradiated buttock skin samples were obtained from two healthy volunteers at 2 days after the irradiation at 2 minimal erythemal doses. Results: In the reticular dermis of young sun- protected skin from the upper arm, fibulin- 5 colocalized with the other elastic fibre components, while in the papillary dermis fibulin- 5 showed candelabra- like structures perpendicular to the epidermiswith an unstained area just beneath the epidermis, which was similar to that of elastin but not fibrillin- 1. Fibulin- 5 in the reticular dermis decreased and disappeared with age even in sun- protected skin from the thigh, abdomen and upper arm. In sun- exposed skin, fibulin- 5 was extremely reduced in the dermis of cheek skin even from a 20- year- old man. UVB irradiation reduced fibulin- 5, fibulin- 2 and elastin markedly, moderately and weakly, respectively, compared with levels in control nontreated skin. Interestingly, the deposition of fibulin- 5 was increased in solar elastosis, like that of other elastic fibre components. Conclusions: These results suggest that fibulin- 5 is a good marker of skin ageing and that the earlier loss of fibulin- 5 may involve age- dependent changes in other elastic fibre components. 展开更多
关键词 FIBULIN-5 组织变性 光性 力蛋白 原纤维蛋白 沉积量 最小红斑量 真皮网状层 真皮乳头层 整形外科
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部